APHRIA INC COM NPV (APHQF)

APHQF
Symbol Name Last Trade Price Change Change (%) Volume




Revenue 1 year Target Price 52 week Range Stock Exchange Last Trade Size

APHRIA INC NPV (OTCMKTS:APHQF) is a stock that’s been powering in an uptrend on the strength of legislative changes here and in Canada, and the anticipation of more to come. In addition, according to Benzinga.com, APHQF is currently at the top of the list “of all the stocks in the The Marijuana Index’s comprehensive list of North American marijuana-related stocks” as far as total performance this year.

Traders will note 52% added to share values of the company over the past month of action. Market participants may want to pay attention to this stock. APHQF is a stock whose past is littered with sudden rips. Moreover, the company has benefitted from a jump in recent trading volume to the tune of just shy of 490% above its longer run average levels.

APHRIA INC NPV (OTCMKTS:APHQF) trumpets itself as a company that produces, supplies, and sells medical cannabis in Canada. Its cannabis products include dried flowers and cannabis oils.

The company sells its products through its online store and telephone orders, as well as MMPR licenced producers. Aphria Inc. is headquartered in Leamington, Canada.

According to company press materials, “Aphria Inc., one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. We are committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. We are the first public licensed producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters.”

Breaking News Arrows

Breaking News

  • CannTrust: Analysts’ Ratings and Target Price in DecemberDecember 20, 2018CannTrust (CNTTF) has been one of the worst performers in the cannabis industry with year-to-date returns of -31.7% as of December 19. The other cannabis stocks (HMMJ) that also delivered a negative return during the same period are Aphria (APHA) (APHQF) and Aurora Cannabis (ACB), which fell 64% and 37.3%, respectively.
  • Cannabis Products: Tilray Partners with AB InBevDecember 20, 2018On December 19, Tilray (TLRY) announced a “research partnership” with one of the largest alcoholic beverage companies—AB InBev. The joint partnership would entail an investment of $100 million or $50 million from each company to advance research in non-alcoholic beverages specifically for the Canadian market. The beverage product research would target both THC (tetrahydrocannabinol) and CBD (cannabidiol) infused drinks. The research might focus on both recreational drinks.
  • Aphria: Analysts’ Recommendations and Target PriceDecember 20, 2018Aphria (APHA) (APHQF) had one of the worst months in December. Aphria stock fell nearly 24%. On December 18, the company announced that it will introduce its oral strip to the German market. The product will work in conjunction with a previously announced agreement with Rapid Dose for the exclusive right to manufacture, license, and distribute Rapid Dose’s QuickStrip oral strip. As a result, the stock rose nearly 7.8% during the day.
  • Tilray: Analysts’ Target Price and Ratings in DecemberDecember 19, 2018Tilray (TLRY) has been among the most volatile stocks compared to other cannabis players (MJ) including Canopy Growth (WEED), Aurora Cannabis (ACBFF), and Aphria (APHQF). The company has returned nearly 241% since its debut in July. Tilray has garnered a lot of attention since its IPO. Earlier this week, the company announced a partnership with Novartis to make co-branded products for international markets.
  • What to Look For as Cannabis Industry Navigates Early YearsDecember 19, 2018The seventh development that we’ll be closely watching in the cannabis sector in 2019 will be the developments in the US. Now that hemp legalization has occurred, it will be interesting to see how the cannabis sector shapes up through the window of hemp products. Without the political will, no regulations around the cannabis sector (MJ) can become a reality.